{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:01:09Z","timestamp":1762077669701,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23 DK085378"],"award-info":[{"award-number":["K23 DK085378"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011912","name":"Washington University School of Medicine in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ahj.2015.07.019","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T10:37:01Z","timestamp":1437907021000},"page":"735-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction"],"prefix":"10.1016","volume":"170","author":[{"given":"James B.","family":"Wetmore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip G.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2015.07.019_bb0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.07.019_bb0010","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.07.019_bb0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","article-title":"Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials","volume":"368","author":"Dagenais","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.07.019_bb0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.07.019_bb0025","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.07.019_bb0030","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.019_bb0035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.019_bb0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.07.019_bb0050","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.07.019_bb0055","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group","volume":"334","author":"Maschio","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.07.019_bb0060","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","author":"The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2015.07.019_bb0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2015.07.019_bb0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000096777","article-title":"Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency","volume":"108","author":"Tessone","year":"2007","journal-title":"Cardiology"},{"key":"10.1016\/j.ahj.2015.07.019_bb0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ahj.2003.12.010","article-title":"Renal insufficiency and mortality from acute coronary syndromes","volume":"147","author":"Masoudi","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2015.07.019_bb0080","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ahj.2007.11.031","article-title":"Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome","volume":"155","author":"Mielniczuk","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2015.07.019_bb0085","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/ndt\/gfh981","article-title":"Renal function, concomitant medication use and outcomes following acute coronary syndromes","volume":"20","author":"Reddan","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ahj.2015.07.019_bb0090","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ahj.2010.08.007","article-title":"The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality","volume":"160","author":"Amin","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2015.07.019_bb0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/CIRCULATIONAHA.111.039909","article-title":"Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry","volume":"125","author":"Fox","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.07.019_bb0100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","volume":"121","author":"Fox","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.07.019_bb0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/CIRCOUTCOMES.110.960468","article-title":"Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry","volume":"4","author":"Arnold","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2015.07.019_bb0110","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.553370","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.07.019_bb0115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2015.07.019_bb0120","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.ahj.2015.07.019_bb0125","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"year":"2002","series-title":"IVEware: Imputation and Variance Estimation Software\u2014user guide","author":"Raghunathan","key":"10.1016\/j.ahj.2015.07.019_bb0130"},{"key":"10.1016\/j.ahj.2015.07.019_bb0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2261-9-29","article-title":"Increased mortality among survivors of myocardial infarction with kidney dysfunction: the contribution of gaps in the use of guideline-based therapies","volume":"9","author":"Peterson","year":"2009","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ahj.2015.07.019_bb0140","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2004.06.072","article-title":"The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease","volume":"44","author":"Ezekowitz","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.019_bb0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0735-1097(03)00572-2","article-title":"Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction","volume":"42","author":"Berger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.019_bb0150","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archinternmed.2012.3093","article-title":"Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice","volume":"172","author":"Amin","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2015.07.019_bb0155","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00467-007-0524-0","article-title":"Mechanisms of progression of chronic kidney disease","volume":"22","author":"Fogo","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ahj.2015.07.019_bb0160","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2215\/CJN.00150106","article-title":"Kidney function and use of recommended medications after myocardial infarction in elderly patients","volume":"1","author":"Winkelmayer","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2015.07.019_bb0165","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0085-2538(15)50905-8","article-title":"Cardiovascular medication use after coronary bypass surgery in patients with renal dysfunction: a national Veterans Administration study","volume":"68","author":"Gibney","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2015.07.019_bb0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2369-12-44","article-title":"Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study","volume":"12","author":"Bansal","year":"2011","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ahj.2015.07.019_bb0175","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1097\/01.ASN.0000146423.71226.0C","article-title":"Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results","volume":"15","author":"Remuzzi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ahj.2015.07.019_bb0180","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jacc.2013.11.031","article-title":"Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data","volume":"63","author":"Damman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2015.07.019_bb0185","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ki.2011.79","article-title":"An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function","volume":"80","author":"Holtkamp","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2015.07.019_bb0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00125-010-1922-6","article-title":"Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial","volume":"54","author":"Miao","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.ahj.2015.07.019_bb0200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2015.07.019_bb0205","first-page":"F275","article-title":"Local upregulation of colonic angiotensin II receptors enhances potassium excretion in chronic renal failure","volume":"274","author":"Hatch","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ahj.2015.07.019_bb0210","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/ajkd.2002.36340","article-title":"ACE inhibitors and survival of hemodialysis patients","volume":"40","author":"Efrati","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2015.07.019_bb0215","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.109.853648","article-title":"Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure","volume":"120","author":"Anand","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2015.07.019_bb0220","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","article-title":"Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial","volume":"56","author":"Cice","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315004597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315004597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:56:11Z","timestamp":1762077371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870315004597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0002870315004597"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2015.07.019","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2015.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}